Schedules of Controlled Substances: Placement of MDMB-4en-PINACA in Schedule I
Comments Off on Schedules of Controlled Substances: Placement of MDMB-4en-PINACA in Schedule I
May 11, 2026
✦ New CED Clinical Relevance #70 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Policy Watch | Federal Register PolicySafetyResearch Clinical Summary This regulatory notice…
Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I
Comments Off on Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I
May 11, 2026
✦ New CED Clinical Relevance #70 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Policy Watch | Federal Register PolicySafety Clinical Summary The Drug Enforcement Administration has…
Schedules of Controlled Substances: Placement of MDMB-4en-PINACA in Schedule I
Comments Off on Schedules of Controlled Substances: Placement of MDMB-4en-PINACA in Schedule I
April 25, 2026
✦ New CED Clinical Relevance #70 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Policy Watch | Federal Register PolicySafetyResearch Clinical Summary The U.S. Drug Enforcement…